Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy
The DOI matches its Crossref record; 283 of the 283 references it cites were found in a registry or an index.
Abstract
PURPOSE: The Cancer Imaging Program of the National Cancer Institute convened a workshop to assess the current status of hypoxia imaging, to assess what is known about the biology of hypoxia as it relates to cancer and cancer therapy, and to define clinical scenarios in which in vivo hypoxia imaging could prove valuable. RESULTS: Hypoxia, or low oxygenation, has emerged as an important factor in tumor biology and response to cancer treatment. It has been correlated with angiogenesis, tumor aggressiveness, local recurrence, and metastasis, and it appears to be a prognostic factor for several cancers, including those of the cervix, head and neck, prostate, pancreas, and brain. The relationship between tumor oxygenation and response to radiation therapy has been well established, but hypoxia also affects and is affected by some chemotherapeutic agents. Although hypoxia is an important aspect of tumor physiology and response to treatment, the lack of simple and efficient methods to measure and image oxygenation hampers further understanding and limits their prognostic usefulness. There is no gold standard for measuring hypoxia; Eppendorf measurement of pO(2) has been used, but this method is invasive. Recent studies have focused on molecular markers of hypoxia, such as hypoxia inducible factor 1 (HIF-1) and carbonic anhydrase isozyme IX (CA-IX), and on developing noninvasive imaging techniques. CONCLUSIONS: This workshop yielded recommendations on using hypoxia measurement to identify patients who would respond best to radiation therapy, which would improve treatment planning. This represents a narrow focus, as hypoxia measurement might also prove useful in drug development and in increasing our understanding of tumor biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Federation Proceedings: Water and Electrolyte Losses in Cholera
Phillips, R. A. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1982.tb05283.x · Cited by 3,934
Tumorigenesis and the angiogenic switch
Bergers, G., & Benjamin, L. E. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1093 · Cited by 3,559
Radiobiology for the Radiologist.
(1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-3-438_1 · Cited by 3,484
Tofts, P. S., Brix, G., Buckley, D. L., Evelhoch, J. L., Henderson, E., Knopp, M. V., Larsson, H. B. W., Lee, T.-Y., Mayr, N. A., Parker, G. J. M., et al. (1999) · Journal of Magnetic Resonance Imaging · doi:10.1002/(sici)1522-2586(199909)10:3<223::aid-jmri2>3.0.co;2-s · Cited by 3,143
Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR
Ardenkjær-Larsen, J. H., Fridlund, B., Gram, A., Hansson, G., Hansson, L., Lerche, M. H., Servin, R., Thaning, M., & Golman, K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1733835100 · Cited by 2,861
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662 · cited 1×
“There appears to be a vicious circle (Hockel & Vaupel 2001a, Hockel & Vaupel 2001b) in which hypoxia-induced changes promote malignant progression and increased aggressiveness, leading to tumor propagation and further tumor hypoxia.”
BackgroundInternational Journal of Oncology
(2026) · International Journal of Oncology · doi:10.3892/ijo · Cited by 2,331
The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy
Thomlinson, R. H., & Gray, L. H. (1955) · British Journal of Cancer · doi:10.1038/bjc.1955.55 · Cited by 2,219
Höckel, M., Schlenger, K., Aral, B., Mitze, M., Schäffer, U., & Vaupel, P. W. (1996) · PubMed · Cited by 1,927
Smithers, D. W. (1956) · The Lancet · doi:10.1016/s0140-6736(56)91184-9 · Cited by 1,791
Heissig, B., Hattori, K., Dias, S., Friedrich, M., Ferris, B., Hackett, N. R., Crystal, R. G., Besmer, P., Lyden, D., Moore, M. A. S., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00754-7 · Cited by 1,751
HIF-1 and mechanisms of hypoxia sensing
Semenza, G. L. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00194-0 · Cited by 1,268
Laughner, E., Taghavi, P., Chiles, K., Mahon, P. C., & Semenza, G. L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.12.3995-4004.2001 · Cited by 1,256 · cited 1×
“…translation of HIF-1a messenger RNA through the phosphatidylinositol 30-kinase and mitogen-activated protein kinase (MAPK) pathways (Brune & Zhou 2003, Fukuda et al. 2002, Fukuda et al. 2003, Laughner et al. 2001, Lukiw et al. 2003, Minet et al. 2001, Pichiule et al. 2004, Semenza 2001a).”
(1996) · PubMed · Cited by 1,188
HIF-1 and tumor progression: pathophysiology and therapeutics
Semenza, G. L. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02317-1 · Cited by 1,060
Self-citationImaging of angiogenesis: from microscope to clinic
McDonald, D. M., & Choyke, P. L. (2003) · Nature Medicine · doi:10.1038/nm0603-713 · Cited by 1,016
Vaupel, P. W., Schlenger, K., Knoop, C., & Höckel, M. (1991) · PubMed · Cited by 952
Fukuda, R., Hirota, K., Fan, F., Jung, Y. D., Ellis, L. M., & Semenza, G. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203781200 · Cited by 821
Radiobiology for the Radiologist
Fowler, J. F., & Hall, E. J. (1988) · Radiation Research · doi:10.2307/3577489 · Cited by 785
Dvorak, H. F., Nagy, J. A., Feng, D., Brown, L. F., & Dvorak, A. M. (1999) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59953-8_6 · Cited by 743
2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF
Mabjeesh, N. J., Escuin, D., LaVallee, T. M., Pribluda, V. S., Swartz, G. M., Johnson, M. S., Willard, M. T., Zhong, H., Simons, J. W., & Giannakakou, P. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00077-1 · Cited by 730
Pancreatic tumors show high levels of hypoxia
Koong, A. C., Mehta, V. K., Le, Q. T., Fisher, G. A., Terris, D. J., Brown, J. M., Bastidas, A. J., & Vierra, M. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00803-8 · Cited by 650
(2003) · PubMed · Cited by 624
(2000) · PubMed · Cited by 614
Kelly, B. D., Hackett, S. F., Hirota, K., Oshima, Y., Cai, Z., Berg-Dixon, S., Rowan, A., Yan, Z., Campochiaro, P. A., & Semenza, G. L. (2003) · Circulation Research · doi:10.1161/01.res.0000102937.50486.1b · Cited by 611
Self-citation(2001) · PubMed · Cited by 605
Zagzag, D., Zhong, H., Scalzitti, J. M., Laughner, E., Simons, J. W., & Semenza, G. L. (2000) · Cancer · doi:10.1002/1097-0142(20000601)88:11<2606::aid-cncr25>3.0.co;2-w · Cited by 604
Bos, R., van der Hoeven, J. J. M., van der Wall, E., van der Groep, P., van Diest, P. J., Comans, E. F. I., Joshi, U., Semenza, G. L., Hoekstra, O. S., Lammertsma, A. A., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.379 · Cited by 591
Statistical aspects of prognostic factor studies in oncology
Simon, R., & Altman, D. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.192 · Cited by 582
Sdol, E. (2009) · Cited by 576
Treatment Resistance of Solid Tumors
Vaupel, P., Thews, O., & Hoeckel, M. (2001) · Medical Oncology · doi:10.1385/mo:18:4:243 · Cited by 558
MRI of the tumor microenvironment
Gillies, R. J., Raghunand, N., Karczmar, G. S., & Bhujwalla, Z. M. (2002) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10181 · Cited by 550
Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome
Brizel, D. M., Dodge, R. K., Clough, R. W., & Dewhirst, M. W. (1999) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(99)00102-4 · Cited by 548
Hofmann, M., Maecke, H., Börner, A., Weckesser, E., Schöffski, P., Oei, M., Schumacher, J., Henze, M., Heppeler, A., Meyer, G., et al. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100639 · Cited by 544
Expression of hypoxia-inducible factor 1: mechanisms and consequences
Semenza, G. L. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00292-0 · Cited by 511
Bos, R., van der Groep, P., Greijer, A. E., Shvarts, A., Meijer, S., Pinedo, H. M., Semenza, G. L., van Diest, P. J., & van der Wall, E. (2003) · Cancer · doi:10.1002/cncr.11246 · Cited by 500
Self-citationNF-κB Mediates αvβ3 Integrin-induced Endothelial Cell Survival
Scatena, M., Almeida, M., Chaisson, M. L., Fausto, N., Nicosia, R. F., & Giachelli, C. M. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.4.1083 · Cited by 485
Loncaster, J. A., Harris, A. L., Davidson, S. E., Logue, J. P., Hunter, R. D., Wycoff, C. C., Pastorek, J., Ratcliffe, P. J., Stratford, I. J., & West, C. (2001) · PubMed · Cited by 482
Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential.
Fujibayashi, Y., Taniuchi, H., Yonekura, Y., Ohtani, H., Konishi, J., & Yokoyama, A. (1997) · PubMed · Cited by 481
Oxygenation status of malignant tumors: Pathogenesis of hypoxia and significance for tumor therapy
VAUPEL, P. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90210-6 · Cited by 479
(2013) · Acta Neurologica Belgica · doi:10.1007/13760.2240-2993 · Cited by 462
Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers.
Weinmann, H., Laniado, M., & Mutzel, W. (1984) · PubMed · Cited by 462
Chao, K. S. C., Bosch, W. R., Mutic, S., Lewis, J. S., Dehdashti, F., Mintun, M. A., Dempsey, J. F., Perez, C. A., Purdy, J. A., & Welch, M. J. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)01433-4 · Cited by 429
Molecular imaging with endogenous substances
Golman, K., Ardenkjær-Larsen, J. H., Petersson, J. S., Månsson, S., & Leunbach, I. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1733836100 · Cited by 427
SR-4233: A new bioreductive agent with high selective toxicity for hypoxic mammalian cells
Zeman, E. M., Brown, J. M., Lemmon, M. J., Hirst, V. K., & Lee, W. W. (1986) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(86)90267-1 · Cited by 402
Tumor Hypoxia Has Independent Predictor Impact Only in Patients With Node-Negative Cervix Cancer
Fyles, A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.3.680 · Cited by 397
Krieg, M., Haas, R., Brauch, H., Acker, T., Flamme, I., & Plate, K. H. (2000) · Oncogene · doi:10.1038/sj.onc.1203938 · Cited by 396 · cited 5×
“b-D-IAZGP beta-D-iodinated azomycin galactopyranoside BFR blood flow rate BOLD MRI blood oxygen level-dependent magnetic resonance imaging CA-4P combretastatin CA-IX carbonic anhydrase isozyme IX CIP Cancer Imaging Program COX-2 cyclooxygenase 2 CT computed tomography Cu-ATSM copper (II) diacetyl-bis(N4)-methylthiosem…”
BackgroundInfluentialHypoxia and Glucose Metabolism in Malignant Tumors
Rajendran, J. G., Mankoff, D. A., O’Sullivan, F., Peterson, L. M., Schwartz, D. L., Conrad, E. U., Spence, A. M., Muzi, M., Farwell, D. G., & Krohn, K. A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0688-3 · Cited by 390
(2002) · PubMed · Cited by 385
Biological consequences of tumor hypoxia
HOCKEL, M. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90211-8 · Cited by 382
In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM
Dehdashti, F., Mintun, M. A., Lewis, J. S., Bradley, J., Govindan, R., Laforest, R., Welch, M. J., & Siegel, B. A. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1130-4 · Cited by 368
FDG Accumulation and Tumor Biology
Pauwels, E. K. J., Ribeiro, M. J., Stoot, J. H. M. B., McCready, V. R., Bourguignon, M., & Mazière, B. (1998) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(97)00226-6 · Cited by 366
SR 4233 (Tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours
Brown, J. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.220 · Cited by 366
Kimura, H., Braun, R. D., Ong, E. T., Hsu, R., Secomb, T. W., Papahadjopoulos, D., Hong, K., & Dewhirst, M. W. (1996) · PubMed · Cited by 364
Airley, R. E., Loncaster, J. A., Davidson, S. E., Bromley, M., Roberts, S. K., Patterson, A. V., Hunter, R. D., Stratford, I. J., & West, C. (2001) · PubMed · Cited by 363
Birner, P., Schindl, M., Obermair, A., Breitenecker, G., & Oberhuber, G. (2001) · PubMed · Cited by 362
Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model.
Lewis, J. S., Mccarthy, D. W., McCarthy, T. J., Fujibayashi, Y., & Welch, M. J. (1999) · PubMed · Cited by 357
Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.
Kaanders, J. H. A. M., Wijffels, K. I. E. M., Marres, H. A. M., Ljungkvist, A. S. E., Pop, L. A. M., van den Hoogen, F. J. A., de Wilde, P. C. M., Bussink, J., Raleigh, J. A., & van der Kogel, A. J. (2002) · PubMed · Cited by 357
Hypoxia Is Important in the Biology and Aggression of Human Glial Brain Tumors
Evans, S. M., Judy, K. D., Dunphy, I., Jenkins, W. T., Hwang, W.-T., Nelson, P. T., Lustig, R. A., Jenkins, K., Magarelli, D. P., Hahn, S. M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1081 · Cited by 356
Gillies, R. J., Raghunand, N., Garcia-Martin, M. L., & Gatenby, R. A. (2004) · IEEE Engineering in Medicine and Biology Magazine · doi:10.1109/memb.2004.1360409 · Cited by 351
Wouters, B. G., & Brown, J. M. (1997) · Radiation Research · doi:10.2307/3579620 · Cited by 341
Radiobiology for the Radiologist
Hendry, J. H. (1979) · British Journal of Cancer · doi:10.1038/bjc.1979.88 · Cited by 340
Galbraith, S. M., Lodge, M. A., Taylor, N. J., Rustin, G. J. S., Bentzen, S., Stirling, J. J., & Padhani, A. R. (2002) · NMR in Biomedicine · doi:10.1002/nbm.731 · Cited by 338
Hui, E. P., Chan, A. T. �., Pezzella, F., Turley, H., To, K., Poon, T. C. W., Zee, B. C.-Y., Mo, F. K. F., Teo, P. M. L., Huang, D. P., et al. (2002) · PubMed · Cited by 333
Fukuda, R., Kelly, B., & Semenza, G. L. (2003) · PubMed · Cited by 326
Dehdashti, F., Grigsby, P. W., Mintun, M. A., Lewis, J. S., Siegel, B. A., & Welch, M. J. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)04477-2 · Cited by 326
In vivo imaging of extracellular pH using1H MRSI
van Sluis, R., Bhujwalla, Z. M., Raghunand, N., Ballesteros, P., Alvarez, J., Cerd�n, S., Galons, J.-P., & Gillies, R. J. (1999) · Magnetic Resonance in Medicine · doi:10.1002/(sici)1522-2594(199904)41:4<743::aid-mrm13>3.0.co;2-z · Cited by 322
Hypoxia inducible factor as a cancer drug target.
Welsh, S., & Powis, G. (2003) · Current Cancer Drug Targets · doi:10.2174/1568009033481732 · Cited by 309
A marker for hypoxic cells in tumours with potential clinical applicability
Chapman, J. D., Franko, A. J., & Sharplin, J. (1981) · British Journal of Cancer · doi:10.1038/bjc.1981.79 · Cited by 306
Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors
Rampling, R., Cruickshank, G., Lewis, A. D., Fitzsimmons, S. A., & Workman, P. (1994) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)90432-4 · Cited by 304
Krishna, M. C., English, S., Yamada, K., Yoo, J., Murugesan, R., Devasahayam, N., Cook, J. A., Golman, K., Ardenkjaer-Larsen, J. H., Subramanian, S., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042671399 · Cited by 304
Topoisomerase I-Mediated Inhibition of Hypoxia-Inducible Factor 1
Rapisarda, A., Uranchimeg, B., Sordet, O., Pommier, Y., Shoemaker, R. H., & Melillo, G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3139 · Cited by 301
Self-citationElson, D. A., Thurston, G., Huang, L. E., Ginzinger, D. G., McDonald, D. M., Johnson, R. S., & Arbeit, J. M. (2001) · Genes & Development · doi:10.1101/gad.914801 · Cited by 299
(2002) · PubMed · Cited by 296
Shi, Q., Abbruzzese, J. L., Huang, S., Fidler, I. J., Xiong, Q., & Xie, K. (1999) · PubMed · Cited by 293
(2001) · PubMed · Cited by 292
Koh, W.-J., Bergman, K. S., Rasey, J. S., Peterson, L. M., Evans, M. L., Graham, M. M., Grierson, J. R., Lindsley, K. L., Lewellen, T. K., Krohn, K. A., et al. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)00170-4 · Cited by 288
von Pawel, J., von Roemeling, R., Gatzemeier, U., Boyer, M., Elisson, L. O., Clark, P., Talbot, D., Rey, A., Butler, T. W., Hirsh, V., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.6.1351 · Cited by 285
Nordsmark, M., & Overgaard, J. (2000) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(00)00223-1 · Cited by 281
Welsh, S. J., Williams, R. R., Kirkpatrick, L., Paine-Murrieta, G. D., & Powis, G. (2004) · PubMed · Cited by 280
Hypoxia-Inducible Factor 1: Control of Oxygen Homeostasis in Health and Disease
Semenza, G. L. (2001) · Pediatric Research · doi:10.1203/00006450-200105000-00002 · Cited by 279
Feng, D., Nagy, J. A., Hipp, J., Dvorak, H. F., & Dvorak, A. M. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.5.1981 · Cited by 278
Copper bis(thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationships
Dearling, J. L. J., Lewis, J. S., Mullen, G. E. D., Welch, M. J., & Blower, P. J. (2002) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s007750100291 · Cited by 277
Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer.
Rudland, P. S., Platt-Higgins, A. M., El‐Tanani, M., Rudland, S. D. S., Barraclough, R., Winstanley, J. H. R., Howitt, R., & West, C. R. (2002) · PubMed · Cited by 276
OGAN, M. D., SCHMIEDL, U., MOSELEY, M. E., GRODD, W., PAAJANEN, H., & BRASCH, R. C. (1987) · Investigative Radiology · doi:10.1097/00004424-198708000-00008 · Cited by 274
Influence of the hypoxic subvolume on the survival of patients with head and neck cancer
Stadler, P., Becker, A., Jürgen Feldmann, H., Hänsgen, G., Dunst, J., Würschmidt, F., & Molls, M. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00115-7 · Cited by 266
Contributions of Cell Metabolism and H+ Diffusion to the Acidic pH of Tumors
Schornack, P. A., & Gillies, R. J. (2003) · Neoplasia · doi:10.1016/s1476-5586(03)80005-2 · Cited by 261
Tumor tissue oxygenation as evaluated by computerized-po2-histography
Kallinowski, F., Zander, R., Hoeckel, M., & Vaupel, P. (1990) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(90)90018-f · Cited by 253
Rischin, D., Peters, L., Fisher, R., Macann, A., Denham, J., Poulsen, M., Jackson, M., Kenny, L., Penniment, M., Corry, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.072 · Cited by 253 · cited 1×
“In a phase II study comparing a regimen combining 5-fluorouracil (5-FU), cisplatin, and radiation with one that combined TPZ, cisplatin, and radiation, the TPZ combination produced a higher percentage of locoregional control and failurefree survival (Rischin et al. 2005).”
BackgroundRajendran, J. G., Wilson, D. C., Conrad, E. U., Peterson, L. M., Bruckner, J. D., Rasey, J. S., Chin, L. K., Hofstrand, P. D., Grierson, J. R., Eary, J. F., et al. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1096-7 · Cited by 252
(2003) · PubMed · Cited by 250
Microenvironmental and cellular consequences of altered blood flow in tumours
Raghunand, N., Gatenby, R. A., & Gillies, R. J. (2003) · The British Journal of Radiology · doi:10.1259/bjr/12913493 · Cited by 240
Welsh, S., Williams, R., Kirkpatrick, L., Paine-Murrieta, G., & Powis, G. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.233.3.3 · Cited by 240
O-charoenrat, P., Rhys-Evans, P., & Eccles, S. A. (2001) · Cancer · doi:10.1002/1097-0142(20010801)92:3<556::aid-cncr1355>3.0.co;2-q · Cited by 232
Tumor Microenvironment and the Response to Anticancer Therapy
Brown, J. M. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.1.5.157 · Cited by 232
Nordsmark, M., Alsner, J., Keller, J., Nielsen, O. S., Jensen, O. M., Horsman, M. R., & Overgaard, J. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1728 · Cited by 226
Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts.
Lord, E. M., Harwell, L. W., & Koch, C. J. (1993) · PubMed · Cited by 223
Assessment of tumor oxygenation by electron paramagnetic resonance: principles and applications
Gallez, B., Baudelet, C., & Jordan, B. F. (2004) · NMR in Biomedicine · doi:10.1002/nbm.900 · Cited by 222
Monitoring photodynamic therapy of solid tumors online by BOLD-contrast MRI
Gross, S., Gilead, A., Scherz, A., Neeman, M., & Salomon, Y. (2003) · Nature Medicine · doi:10.1038/nm940 · Cited by 219
Baudelet, C., & Gallez, B. (2002) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10318 · Cited by 218
The measurement of oxygen in vivo using EPR techniques
Swartz, H. M., & Clarkson, R. B. (1998) · Physics in Medicine and Biology · doi:10.1088/0031-9155/43/7/017 · Cited by 218
Cairns, R. A., & Hill, R. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3196 · Cited by 216
Le, Q., Sutphin, P. D., Raychaudhuri, S., Yu, S. C. T., Terris, D. J., Lin, H. S., Lum, B. L., Pinto, H. A., Koong, A. C., & Giaccia, A. J. (2003) · PubMed · Cited by 216
Comparative Measurements of Hypoxia in Human Brain Tumors Using Needle Electrodes and EF5 Binding
Evans, S. M., Judy, K. D., Dunphy, I., Jenkins, W. T., Nelson, P. T., Collins, R., Wileyto, E. P., Jenkins, K., Hahn, S. M., Stevens, C. W., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2424 · Cited by 216
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Oncology
Knopp, M. V., Giesel, F. L., Marcos, H. B., von Tengg‐Kobligk, H., & Choyke, P. L. (2001) · Topics in Magnetic Resonance Imaging · doi:10.1097/00002142-200108000-00006 · Cited by 215
Hypoxic Regulation of Angiopoietin-2 Expression in Endothelial Cells
Pichiule, P., Chavez, J. C., & LaManna, J. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m305146200 · Cited by 210
Knocke, T.-H., Weitmann, H.-D., Feldmann, H.-J., Selzer, E., & Pötter, R. (1999) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(99)00139-5 · Cited by 210
Hypoxic Sensitizers — Implications for Radiation Therapy
Chapman, J. D. (1979) · New England Journal of Medicine · doi:10.1056/nejm197912273012606 · Cited by 210
Hypoxia in Breast Cancer: Pathogenesis, Characterization and Biological/Therapeutic Implications
Vaupel, P., Briest, S., & Hockel, M. (2002) · Wiener Medizinische Wochenschrift · doi:10.1046/j.1563-258x.2002.02032.x · Cited by 209
Koch, C. J. (2002) · Methods in Enzymology · doi:10.1016/s0076-6879(02)52003-6 · Cited by 207
Khanna, C., Prehn, J., Yeung, C., Caylor, J., Tsokos, M., & Helman, L. (2000) · Clinical & Experimental Metastasis · doi:10.1023/a:1006767007547 · Cited by 207 · cited 1×
“Similar correlations have been demonstrated in the lung (Chambers et al. 1996, Khanna et al. 2000, Schneider et al. 2004, Shijubo et al. 1999, Urquidi et al. 2002) and colon (Yeatman & Chambers 2003).”
ResultRischin, D., Peters, L., Hicks, R., Hughes, P., Fisher, R., Hart, R., Sexton, M., D’Costa, I., & von Roemeling, R. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.535 · Cited by 201
Bayés, M., Rabasseda, X., & Prous, J. (2002) · PubMed · Cited by 200
Koukourakis, M. I., Giatromanolaki, A. N., Sivridis, E., Simopoulos, K., Pastorek, J., Wykoff, C. C., Gatter, K. C., & Harris, A. L. (2001) · PubMed · Cited by 200
Quantitative “magnetic resonance immunohistochemistry” with ligand‐targeted 19F nanoparticles
Morawski, A. M., Winter, P. M., Yu, X., Fuhrhop, R. W., Scott, M. J., Hockett, F., Robertson, J. D., Gaffney, P. J., Lanza, G. M., & Wickline, S. A. (2004) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20287 · Cited by 192
Tuck, A. B., Arsenault, D., O’Malley, F. P., Hota, C., Ling, M. C., Wilson, S. M., & Chambers, A. F. (1999) · Oncogene · doi:10.1038/sj.onc.1202799 · Cited by 191
Osteopontin expression in lung cancer
Chambers, A. F., Wilson, S. M., Kerkvliet, N., O'Malley, F. P., Harris, J. F., & Casson, A. G. (1996) · Lung Cancer · doi:10.1016/0169-5002(95)00595-1 · Cited by 189
Reproducibility of quantitative dynamic MRI of normal human tissues
Padhani, A. R., Hayes, C., Landau, S., & Leach, M. O. (2002) · NMR in Biomedicine · doi:10.1002/nbm.732 · Cited by 188
Movsas, B., Chapman, J. D., Hanlon, A. L., Horwitz, E. M., Greenberg, R. E., Stobbe, C., Hanks, G. E., & Pollack, A. (2002) · Urology · doi:10.1016/s0090-4295(02)01858-7 · Cited by 188
Antitumor activity of the novel vascular targeting agent ZD6126 in a panel of tumor models.
Blakey, D. C., Westwood, F. R., Walker, M., Hughes, G. D., Davis, P. D., Ashton, S., & Ryan, A. J. (2002) · PubMed · Cited by 188
Rapisarda, A., Zalek, J., Hollingshead, M., Braunschweig, T., Uranchimeg, B., Bonomi, C. A., Borgel, S. D., Carter, J. P., Hewitt, S. M., Shoemaker, R. H., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2116 · Cited by 187
Lewis, J. S., Sharp, T. L., Laforest, R. A., Fujibayashi, Y., & Welch, M. J. (2001) · PubMed · Cited by 187
Issues in flow and oxygenation dependent contrast (FLOOD) imaging of tumours
Howe, F. A., Robinson, S. P., McIntyre, D. J. O., Stubbs, M., & Griffiths, J. R. (2001) · NMR in Biomedicine · doi:10.1002/nbm.716 · Cited by 183
BOLD MRI of human tumor oxygenation during carbogen breathing
Taylor, N. J., Baddeley, H., Goodchild, K. A., Powell, M. E. B., Thoumine, M., Culver, L. A., Stirling, J. J., Saunders, M. I., Hoskin, P. J., Phillips, H., et al. (2001) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1166 · Cited by 183
Brown, J. M., & Lemmon, M. J. (1990) · PubMed · Cited by 181
Martin Brown, J., Yu, N. Y., Brown, D. M., & Lee, W. W. (1981) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(81)90460-0 · Cited by 179
Transduction pathways involved in Hypoxia-Inducible Factor-1 phosphorylation and activation
Minet, E., Michel, G., Mottet, D., Raes, M., & Michiels, C. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00657-8 · Cited by 179
Koch, C., Evans, S., & Lord, E. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.426 · Cited by 178
Zhu, B., Suzuki, K., Goldberg, H. A., Rittling, S. R., Denhardt, D. T., McCulloch, C. A. G., & Sodek, J. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.10394 · Cited by 172
Hypoxic regions exist in human prostate carcinoma
Movsas, B., Chapman, J. D., Horwitz, E. M., Pinover, W. H., Greenberg, R. E., Hanlon, A. L., Iyer, R., & Hanks, G. E. (1999) · Urology · doi:10.1016/s0090-4295(98)00500-7 · Cited by 171
Collingridge, D. R., Piepmeier, J. M., Rockwell, S., & Knisely, J. P. S. (1999) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(99)00121-8 · Cited by 164
Port, R. E., Knopp, M. V., & Brix, G. (2001) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1137 · Cited by 159
Parliament, M., Chapman, J., Urtasun, R., McEwan, A., Golberg, L., Mercer, Jr., Mannan, R., & Wiebe, L. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.17 · Cited by 158
García‐Martín, M. L., Herigault, G., Rémy, C., Farion, R., Ballesteros, P., Coles, J. A., Cerdán, S., & Ziegler, A. (2001) · PubMed · Cited by 156
Su, M., Cheung, Y., Fruehauf, J. P., Yu, H. J., Nalcioğlu, O., Mechetner, E. B., Kyshtoobayeva, A. S., Chen, S., Hsueh, S., McLaren, C. E., et al. (2003) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10380 · Cited by 155
Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature
Dewhirst, M. W., Tso, C. Y., Oliver, R., Gustafson, C. S., Secomb, T. W., & Gross, J. F. (1989) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(89)90375-1 · Cited by 153
Tumor-specific, schedule-dependent interaction between tirapazamine (SR 4233) and cisplatin.
Dorie, M. J., & Brown, J. M. (1993) · PubMed · Cited by 143
Dolbier, W. R., Li, A., Koch, C. J., Shiue, C., & Kachur, A. V. (2001) · Applied Radiation and Isotopes · doi:10.1016/s0969-8043(00)00102-0 · Cited by 141
Hypoxia-inducible factor 1 (HIF-1) in cancer
Quintero, M., Mackenzie, N., & Brennan, P. A. (2004) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2004.03.008 · Cited by 139
Clinical applications of EPR: overview and perspectives
Swartz, H. M., Khan, N. I., Buckey, J. C., Comi, R. J., Gould, L. J., Grinberg, O. Y., Hartford, A. C., Hopf, H. W., Hou, H. G., Hug, E. B., et al. (2004) · NMR in Biomedicine · doi:10.1002/nbm.911 · Cited by 138
Jordan, B. F., Runquist, M. L., Raghunand, N., Baker, A. F., Williams, R. R., Kirkpatrick, L., Powis, G., & Gillies, R. J. (2005) · Neoplasia · doi:10.1593/neo.04628 · Cited by 138
Hexafluorobenzene: a Sensitive 19F NMR Indicator of Tumor Oxygenation
Mason, R. P., Rodbumrung, W., & Antich, P. P. (1996) · NMR in Biomedicine · doi:10.1002/(sici)1099-1492(199605)9:3<125::aid-nbm405>3.0.co;2-f · Cited by 137
Noninvasive imaging of tumor hypoxia in rats using the 2-nitroimidazole 18F-EF5
Ziemer, L. S., Evans, S. M., Kachur, A. V., Shuman, A. G., Cardi, C. A., Jenkins, W. T., Karp, J. S., Alavi, A., Dolbier, W. R., & Koch, C. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1037-5 · Cited by 136
Physiologic measurements by contrast‐enhanced MR imaging: Expectations and limitations
Roberts, T. P. L. (1997) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880070112 · Cited by 135
Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer
Parker, C. C., Milosevic, M., Toi, A., Sweet, J., Panzarella, T., Bristow, R. G., Catton, C., Catton, P. A., Crook, J. M., Gospodarowicz, M. K., et al. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)01621-3 · Cited by 134
Daniels, J. S., & Gates, K. S. (1996) · Journal of the American Chemical Society · doi:10.1021/ja9510774 · Cited by 134
Unusual oxygen concentration dependence of toxicity of SR-4233, a hypoxic cell toxin.
Koch, C. J. (1993) · PubMed · Cited by 132
Combined vascular and extracellular pH imaging of solid tumors
Bhujwalla, Z. M., Artemov, D., Ballesteros, P., Cerdán, S., Gillies, R. J., & Solaiyappan, M. (2002) · NMR in Biomedicine · doi:10.1002/nbm.743 · Cited by 132
Endogenous Markers of Tumor Hypoxia
Vordermark, D., & Brown, J. M. (2003) · Strahlentherapie und Onkologie · doi:10.1007/s00066-003-1150-9 · Cited by 128
Ran, S., Gao, B., Duffy, S. L., Watkins, L. R., Rote, N., & Thorpe, P. E. (1998) · PubMed · Cited by 128
Vascular Endothelial Growth Factor and Osteopontin in Stage I Lung Adenocarcinoma
Shijubo, N., UEDE, T., KON, S., MAEDA, M., SEGAWA, T., Imada, A., HIRASAWA, M., & ABE, S. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.4.9807094 · Cited by 128
Falk, S., Ward, R., & Bleehen, N. M. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.386 · Cited by 128
Checkley, D., Tessier, J. J. L., Kendrew, J., Waterton, J. C., & Wedge, S. R. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601386 · Cited by 128
Vengellur, A., WOODS, B. G., Ryan, H. E., Johnson, R. S., & LaPres, J. J. (2003) · Gene Expression · doi:10.3727/000000003108749062 · Cited by 124
Change of Oxygen Pressure in Glioblastoma Tissue Under Various Conditions
Beppu, T., Kamada, K., Yoshida, Y., Arai, H., Ogasawara, K., & Ogawa, A. (2002) · Journal of Neuro-Oncology · doi:10.1023/a:1015832726054 · Cited by 123
Lukiw, W. J., Ottlecz, A., Lambrou, G. Ι., Grueninger, M., Finley, J., Thompson, H. W., & Bazan, N. G. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-0655 · Cited by 122
Abramovitch, R., Dafni, H., Smouha, E., Benjamin, L. E., & Neeman, M. (1999) · PubMed · Cited by 121
Hunjan, S., Zhao, D., Constantinescu, A., Hahn, E. W., Antich, P. P., & Mason, R. P. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)01460-7 · Cited by 118
Hedley, D. W., Pintilie, M., Woo, J. M. P., Morrison, A. J., Birle, D. C., Fyles, A., Milosevic, M., & Hill, R. P. (2003) · PubMed · Cited by 117
Tirapazamine: a hypoxia-activated topoisomerase II poison.
Peters, K. B., & Brown, J. M. (2002) · PubMed · Cited by 117
Bhujwalla, Z. M., Artemov, D., Natarajan, K., Ackerstaff, E., & Solaiyappan, M. (2001) · Neoplasia · doi:10.1038/sj.neo.7900129 · Cited by 117
Rijpkema, M., Kaanders, J. H. A. M., Joosten, F. B. M., van der Kogel, A. J., & Heerschap, A. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02825-0 · Cited by 117
Turetschek, K., Preda, A., Novikov, V., Brasch, R. C., Weinmann, H. J., Wunderbaldinger, P., & Roberts, T. P. L. (2004) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20049 · Cited by 115
The Role of Nitric Oxide (NO) in Stability Regulation of Hypoxia Inducible Factor-1α (HIF-1α)
Brüne, B., & Zhou, J. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457746 · Cited by 113
Measuring Changes in Tumor Oxygenation
Zhao, D., Jiang, L., & Mason, R. P. (2004) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)86018-x · Cited by 112
Anderson, R. F., Shinde, S. S., Hay, M. P., Gamage, S. A., & Denny, W. A. (2002) · Journal of the American Chemical Society · doi:10.1021/ja0209363 · Cited by 111
Expression of hypoxia-inducible factor-1α in cervical carcinomas: correlation with tumor oxygenation
Haugland, H. K., Vukovic, V. M., Pintilie, M., Fyles, A., Milosevic, M., Hill, R. P., & Hedley, D. W. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02815-8 · Cited by 108
Non-invasive determination of tumor oxygen tension and local variation with growth
Mason, R. P., Antich, P. P., Babcock, E. E., Constantinescu, A., Peschke, P., & Hahn, E. W. (1994) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)90231-3 · Cited by 106
Somberg, J. C. (2004) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000136823.57103.9b · Cited by 105
Effect of the Tumor Vascular-Damaging Agent, ZD6126, on the Radioresponse of U87 Glioblastoma
Wachsberger, P. R., Burd, R., Marero, N., Daskalakis, C., Ryan, A. J., McCue, P. A., & Dicker, A. P. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.835.11.2 · Cited by 105
Maxwell, R. J., Wilson, J., Prise, V. E., Vojnovic, B., Rustin, G. J. S., Lodge, M. A., & Tozer, G. M. (2002) · NMR in Biomedicine · doi:10.1002/nbm.754 · Cited by 104
Al‐Hallaq, H., River, J. N., Zamora, M. A., Oikawa, H., & Karczmar, G. S. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00038-8 · Cited by 103
Das, R., Mahabeleshwar, G. H., & Kundu, G. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310256200 · Cited by 103
Urquidi, V., Sloan, D. D., Kawai, K., Agarwal, D., Woodman, A., Tarin, D., & Goodison, S. (2002) · PubMed · Cited by 102
Dafni, H., Landsman, L., Schechter, B., Kohen, F., & Neeman, M. (2002) · NMR in Biomedicine · doi:10.1002/nbm.724 · Cited by 101
Microtubule Disruption Utilizes an NFκB-dependent Pathway to Stabilize HIF-1α Protein
Jung, Y.-J., Isaacs, J. S., Lee, S., Trepel, J., & Neckers, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209804200 · Cited by 99
2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors.
Evans, S. M., Jenkins, W. T., Joiner, B., Lord, E. M., & Koch, C. J. (1996) · PubMed · Cited by 98
Rowe, J. D. D., Scott, C., Werner‐Wasik, M., Bahary, J.-P., Curran, W. J., Urtasun, R. C., & Fisher, B. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.6.1254 · Cited by 98
Lu, Z., Wang, X., Parker, D. L., Goodrich, K. C., & Buswell, H. R. (2003) · Bioconjugate Chemistry · doi:10.1021/bc0340464 · Cited by 98
Lewis, J. S., Herrero, P., Sharp, T. L., Engelbach, J. A., Fujibayashi, Y., Laforest, R. A., Kovács, A. D., Gropler, R. J., & Welch, M. J. (2002) · PubMed · Cited by 97
Measurement of hypoxia in human tumours by non-invasive spect imaging of iodoazomycin arabinoside.
Urtasun, R. C., Parliament, M. B., McEwan, A. J. B., Mercer, J. R., Mannan, R., Wiebe, L. I., Morin, C. M., & Chapman, J. D. (1996) · Europe PMC (PubMed Central) · Cited by 95
Characterization of [18F]fluoroetanidazole, a new radiopharmaceutical for detecting tumor hypoxia.
Rasey, J. S., Hofstrand, P. D., Chin, L. K., & Tewson, T. J. (1999) · PubMed · Cited by 94
Subramanian, S., Matsumoto, K., Mitchell, J. B., & Krishna, M. C. (2004) · NMR in Biomedicine · doi:10.1002/nbm.897 · Cited by 94
Osteopontin is required for full expression of the transformed phenotype by the ras oncogene
Wu, Y., Denhardt, D. T., & Rittling, S. R. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1200 · Cited by 93
Howe, F. A., Robinson, S. P., Rodrigues, L. M., & Griffiths, J. R. (1999) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(99)00089-2 · Cited by 93
Perfluorocarbon imaging in vivo: A 19F MRI study in tumor-bearing mice
Mason, R. P., Antich, P. P., Babcock, E. E., Gerberich, J. L., & Nunnally, R. L. (1989) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(89)90402-5 · Cited by 93
ZANZONICO, P. B., O’Donoghue, J. A., Chapman, J. D., Schneider, R. F., Cai, S., Larson, S. M., Wen, B., Chen, Y., Finn, R. D., Ruan, S., et al. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1322-y · Cited by 93
Barthel, H., Wilson, H., Collingridge, D. R., Brown, G., Osman, S., Luthra, S. K., Brady, F., Workman, P., Price, P. M., & Aboagye, E. O. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601862 · Cited by 92
Ballinger, J. R., Kee, J. W. M., & Rauth, A. M. (1996) · PubMed · Cited by 92
Intratumoral oxygen tension in metastatic melanoma
Lartigau, E. F., Randrianarivelo, H., Avril, M., Margulis, A., Spatz, A., ge, F. E., & Guichard, M. (1997) · Melanoma Research · doi:10.1097/00008390-199710000-00006 · Cited by 91
Relationship of hypoxia to metastatic ability in rodent tumours
Jaeger, K. D., Kavanagh, M.-C., & Hill, R. P. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1743 · Cited by 90
Yamada, K., Kuppusamy, P., English, S. J., Yoo, J., Irie, A., Subramanian, S., Mitchell, J. B., & Krishna, M. C. (2002) · Acta Radiologica · doi:10.1034/j.1600-0455.2002.430418.x · Cited by 89
Tumor R2* is a prognostic indicator of acute radiotherapeutic response in rodent tumors
Rodrigues, L. M., Howe, F. A., Griffiths, J. R., & Robinson, S. P. (2004) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20024 · Cited by 88
Rudat, V., Vanselow, B., Wollensack, P., Bettscheider, C., Osman-Ahmet, S., Eble, M. J., & Dietz, A. (2000) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(00)00200-0 · Cited by 87
Lyng, H., Sundfør, K., Tropé, C. G., & Rofstad, E. K. (2000) · PubMed · Cited by 87
The labelling of EMT-6 tumours in BALB/C mice with14C-misonidazole
Garrecht, B. M., & Chapman, J. D. (1983) · British Journal of Radiology · doi:10.1259/0007-1285-56-670-745 · Cited by 84
Oliver, R., Woodwards, R. T. M., Sloan, P., Thakker, N., Stratford, I. J., & Airley, R. E. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.10.024 · Cited by 83
Tumor Oxygen Dynamics: Correlation of In Vivo MRI with Histological Findings
Zhao, D., Ran, S., Constantinescu, A., Hahn, E. W., & Mason, R. P. (2003) · Neoplasia · doi:10.1016/s1476-5586(03)80024-6 · Cited by 82
Cited by
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
Targeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172
Drug Resistance and the Solid Tumor Microenvironment
Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm135 · Cited by 2,116
Hypoxia, DNA repair and genetic instability
Bristow, R. G., & Hill, R. P. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2344 · Cited by 1,140
Defining normoxia, physoxia and hypoxia in tumours—implications for treatment response
McKeown, S. R. (2014) · The British Journal of Radiology · doi:10.1259/bjr.20130676 · Cited by 1,050
Metadata
- Authors
- Tatum, J. L.
- Venue
- International Journal of Radiation Biology
- Publisher
- Informa UK Limited
- Published
- 2006-01
- Volume
- 82
- Issue
- 10
- Pages
- 699-757
- ISSN
- 0955-3002 (ISSN-L)
- 1362-3095
- OpenAlex
- W2116263694
- Cited by
- 620
- References
- 283
- FWCI
- 13.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.